3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Suspended
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Depressive Disorder, Major
1
Breast Neoplasms
1
Interventions
Specimen Handling
4
Paclitaxel
4
Magnetic Resonance Spectroscopy
4
Trastuzumab
2
Taxes
2
Tamoxifen
2
Interleukin-2
2
Fluorouracil
2
Cyclophosphamide
2
Biopsy
2
Anastrozole
2
trastuzumab biosimilar HLX02
1
taletrectinib
1
palbociclib
1
fluzoparib
1
exemestane
1
eribulin
1
binimetinib
1
aldesleukin
1
Tomography, Optical Coherence
1
Testosterone Propionate
1
Testosterone
1
Tablets
1
Receptors, Chimeric Antigen
1
Radiotherapy
1
Radiosurgery
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
Escitalopram
×
Breast
×
Clear all
NCT04973930
2025-05-13
IPT
New York State Psychiatric Institute
Phase 3
Suspended
20 enrolled